| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $6.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.1B | $1.1B | $1.1B | $0.8B | $0.8B | $0.7B | $0.9B | $0.8B |
| Operating Income | $1.1B | $1.1B | $0.8B | $-0.1B | $-0.4B | $-1.2B | $0.9B | $0.7B |
| Net Income | $0.3B | $0.5B | $0.7B | $-0.4B | $-0.8B | $-2.1B | $0.1B | $0.6B |
| EPS (Basic) | $3.16 | $4.56 | $6.49 | $-3.73 | $-6.64 | $-19.37 | $1.15 | $5.37 |
| EPS (Diluted) | $3.14 | $4.35 | $6.32 | $-3.73 | $-6.64 | $-19.37 | $1.15 | $5.35 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.1B | $13.0B | $14.0B | $13.4B | $12.5B | $13.9B | $13.9B | $13.2B |
| Current Assets | $2.7B | $2.9B | $4.2B | $4.0B | $2.9B | $3.8B | $2.9B | $2.6B |
| Cash & Equivalents | $1.5B | $2.4B | $2.9B | $3.7B | $2.5B | $3.5B | $2.4B | $2.2B |
| Total Liabilities | $14.1B | $13.9B | $15.1B | $15.1B | $13.4B | $14.6B | $12.3B | $11.4B |
| Current Liabilities | $1.6B | $1.5B | $2.2B | $1.8B | $1.3B | $1.9B | $2.0B | $1.9B |
| Stockholders' Equity | $-0.3B | $-0.2B | $-0.3B | $-0.8B | $-0.2B | $-0.4B | $1.7B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.4B | $1.2B | $-0.1B | $-0.2B | $-1.1B | $0.9B | $1.0B |
| Investing Cash Flow | $-1.7B | $-0.1B | $-1.3B | $1.3B | $-0.3B | $-0.3B | $-1.1B | $-1.2B |
| Capital Expenditures | $0.7B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $1.1B | $1.5B |
| Financing Cash Flow | $-0.7B | $-1.8B | $-0.7B | $-0.0B | $-0.4B | $2.5B | $0.3B | $-0.3B |